Selective internal radiation therapy dosimetry.

Abstract

Future OncologyVol. 10, No. 15s Symposium PaperSelective internal radiation therapy dosimetryAndrew KennedyAndrew Kennedy*Radiation Oncology Research, Sarah Cannon Research Institute, 3322 West End Avenue, Suite 800 Nashville, TN 37203, USA; E-mail Address: andrew.kennedy@scresearch.netSearch for more papers by this authorPublished Online:5 Dec 2014https://doi.org/10.2217/fon.14.230AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: dosimetryradioembolization-induced liver diseaseselective internal radiation therapyReferences1 Sarfaraz M, Kennedy AS, Lodge MA, Li XA, Wu X, Yu CX. Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma. Med. Phys. 31(9), 2449–2453 (2004).Crossref, Medline, Google Scholar2 Jackson A, Ten Haken RK, Robertson JM, Kessler ML, Kutcher GJ, Lawrence TS. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int. J. Radiat. Oncol. Biol. Phys. 31(4), 883–891 (1995).Crossref, Medline, CAS, Google Scholar3 Sangro B, Gil-Alzugaray B, Rodriguez J et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 112(7), 1538–1546 (2008).Crossref, Medline, Google Scholar4 Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int. J. Radiat. Oncol. Biol. Phys. 31(5), 1237–1248 (1995).Crossref, Medline, CAS, Google Scholar5 Gil-Alzugaray B, Chopitea A, Iñarrairaegui M et al. Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology 57(3), 1078–1087 (2013).Crossref, Medline, CAS, Google Scholar6 Kennedy AS, Mcneillie P, Dezarn WA et al. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int. J. Radiat. Oncol. Biol. Phys. 74(5), 1494–1500 (2009).Crossref, Medline, CAS, Google Scholar7 Kennedy A, Ball D, Cohen SEA. Safety and efficacy of resin 90Y-microspheres in 548 patients with colorectal liver metastases progressing on systemic chemotherapy. Presented at: 2013 ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, 24–26 January 2013.Crossref, Google Scholar8 Bester L, Meteling B, Pocock N et al. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients. J. Vasc. Interv. Radiol. 23(1), 96–105 (2012).Crossref, Medline, Google Scholar9 Cosimelli M, Golfieri R, Cagol PP et al. Multi-centre Phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br. J. Cancer 103(3), 324–331 (2010).Crossref, Medline, CAS, Google Scholar10 Hendlisz A, Van Den Eynde M, Peeters M et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J. Clin. Oncol. 28(23), 3687–3694 (2010).Crossref, Medline, CAS, Google Scholar11 Sangro B, Carpanese L, Cianni R et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona Clinic Liver Cancer stages: a European evaluation. Hepatology 54(3), 868–878 (2011).Crossref, Medline, Google Scholar12 Kao YH, Tan EH, Ng CE, Goh SW. Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review. Ann. Nucl. Med. 25(7), 455–461 (2011).Crossref, Medline, Google Scholar13 Kao YH, Hock Tan AE, Burgmans MC et al. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. J. Nucl. Med. 53(4), 559–566 (2012).Crossref, Medline, CAS, Google Scholar14 Lau WY, Kennedy AS, Kim YH et al. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int. J. Radiat. Oncol. Biol. Phys. 82(1), 401–407 (2012).Crossref, Medline, Google ScholarFiguresReferencesRelatedDetailsCited ByLiterature Review on Pricing of Initial Discharge Right of SewageInternational Journal of Ecology, Vol. 08, No. 02The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization10 July 2018 | PLOS ONE, Vol. 13, No. 7A dosimetric model for the heterogeneous delivery of radioactive nanoparticles In vivo: a feasibility study17 March 2017 | Radiation Oncology, Vol. 12, No. 1 Vol. 10, No. 15s eToC Sign up Follow us on social media for the latest updates Metrics Downloaded 56 times History Published online 5 December 2014 Published in print November 2014 Information© Future Medicine LtdKeywordsdosimetryradioembolization-induced liver diseaseselective internal radiation therapyFinancial & competing interests disclosureA Kennedy has received research funding from Sirtex Medical Ltd. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.The author would like to thank Rae Hobbs (of Scribe Medical) for her editorial assistance in the development of this paper, funded by Sirtex Medical Ltd.PDF download